Revolution Medicines (RVMD) stock, explained like you're 5

Is Revolution Medicines a small, medium or large cap company?

Yes. Revolution Medicines is a large cap stock. Its market cap, which is the total value of all its shares, is about 40.7 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Revolution Medicines makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves RVMD stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• Revolution Medicines Stock In Focus After EU Drug Backing (Yahoo Finance)
• What's Going On With Revolution Medicines Stock Friday? Revolution Medicines (NASDAQ:RVMD) (Benzinga)
• Revolution Medicines (RVMD) Could Be 31% Below Fair Value Following EU RASONQUE Backing (Simply Wall Street)
• RVMD Stock Stays Flat Despite FDA Nod For $39,800 A Month Pancreatic Cancer Pill Is Drug Price Overshadowing Approval? (Stocktwits)
• Why Moderna Stock, Novavax, and Revolution Medicines Are Slumping Today (Barron's)

Key terms to know before you follow RVMD

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility